Windham Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Windham Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,212	Closed	-$1.27M	–	83
2023 Q4	$1.27M	Buy	14,212 +2	+0%	+$149	0.47%	47
2023 Q3	$1.04M	Hold	14,210	–	–	0.42%	51
2023 Q2	$1.18M	Hold	14,210	–	–	0.46%	48
2023 Q1	$1.08M	Buy	14,210 +710	+5%	+$58.9K	0.43%	48
2022 Q4	$1.12M	Hold	13,500	–	–	0.43%	39
2022 Q3	$1.07M	Hold	13,500	–	–	0.4%	42
2022 Q2	$1M	Hold	13,500	–	–	0.24%	44
2022 Q1	$1.21M	Hold	13,500	–	–	0.26%	41
2021 Q4	$1.51M	Hold	13,500	–	–	0.31%	41
2021 Q3	$1.7M	Hold	13,500	–	–	0.35%	38
2021 Q2	$1.83M	Hold	13,500	–	–	0.37%	35
2021 Q1	$1.83M	Hold	13,500	–	–	0.39%	35
2020 Q4	$1.9M	Hold	13,500	–	–	0.41%	33
2020 Q3	$1.5M	Hold	13,500	–	–	0.34%	36
2020 Q2	$1.51M	Hold	13,500	–	–	0.34%	32
2020 Q1	$1.04M	Hold	13,500	–	–	0.25%	35
2019 Q4	$1.28M	Hold	13,500	–	–	0.28%	44
2019 Q3	$1.03M	Hold	13,500	–	–	0.23%	39
2019 Q2	$1.18M	Hold	13,500	–	–	0.2%	35
2019 Q1	$1.22M	Buy	+13,500	New	+$1.15M	0.2%	35

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Windham Capital Management's XBI Position: Q1 2024 in Review

Windham Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 14,212 shares — an estimated $1.27M sold.

Windham Capital Management first reported a position in XBI in Q1 2019 and held it in 20 quarters. The position peaked at $1.9M in Q4 2020. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Windham Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Windham Capital Management sold 14,212 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $1.27M.
Windham Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 20 quarters.
Windham Capital Management's State Street SPDR S&P Biotech ETF position peaked at $1.9M in Q4 2020.
780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Windham Capital Management's 13F filing for Q1 2024, filed 13 May 2024.